Literature DB >> 1718801

Adhesion molecules in human islet beta-cells. De novo induction of ICAM-1 but not LFA-3.

M Vives1, G Soldevila, L Alcalde, C Lorenzo, N Somoza, R Pujol-Borrell.   

Abstract

Understanding how T lymphocytes recognize beta-cell autoantigens is essential for the elucidation of the pathogenesis of insulin-dependent diabetes mellitus. The increased and ectopic expression of HLA class I and II molecules detected in human beta-cells may facilitate this interaction. T-lymphocyte recognition of surface antigens also involves adhesion accessory molecules: intercellular adhesion molecule 1 (ICAM-1) and lymphocyte function-associated antigen 3 (LFA-3). These molecules not only allow cell contact but can also provide costimulatory signals for T-lymphocyte activation. Levels of ICAM-1 and LFA-3 expression in normal human islet cells and regulation of their expression by cytokines interferon-gamma (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), interleukin 1 beta (IL-1 beta), and IL-6 have been studied by two-color immunofluorescence staining of pancreatic cryostat sections and fluorescence-activated cell sorter analysis. Neither ICAM-1 nor LFA-3 could be demonstrated in sections or in fresh cell preparations, but after 18 h of culture, beta-, alpha-, and delta-cells expressed spontaneously moderate levels of ICAM-1 (but not LFA-3). IFN-gamma and TNF-alpha alone or in combination strongly enhanced this spontaneous expression of ICAM-1 in a time- and/or dose-dependent and additive manner but had no effect on LFA-3. An SV40-transformed islet cell line showed high basal levels of both ICAM-1 and LFA-3, but the response to cytokines followed the same pattern as primary cultures.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1718801     DOI: 10.2337/diab.40.11.1382

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  9 in total

1.  Prevention of reovirus type 2-induced diabetes-like syndrome in DBA/1 suckling mice by treatment with antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1.

Authors:  T Hayashi; S Yamamoto; T Onodera
Journal:  Int J Exp Pathol       Date:  1995-12       Impact factor: 1.925

Review 2.  Immune cell trafficking to the islets during type 1 diabetes.

Authors:  A M Sandor; J Jacobelli; R S Friedman
Journal:  Clin Exp Immunol       Date:  2019-08-30       Impact factor: 4.330

3.  Interleukin-1 promotes hyperglycemia and insulitis in mice normally resistant to streptozotocin-induced diabetes.

Authors:  S J Zunino; L F Simons; J F Sambrook; M J Gething
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

4.  Tumor necrosis factor-alpha modifies adhesion properties of rat islet B cells.

Authors:  V Cirulli; P A Halban; D G Rouiller
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

5.  Adoptive transfer of diabetes to and from old normoglycaemic BB rats.

Authors:  P MacKay
Journal:  Diabetologia       Date:  1995-02       Impact factor: 10.122

6.  Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients.

Authors:  N Itoh; T Hanafusa; A Miyazaki; J Miyagawa; K Yamagata; K Yamamoto; M Waguri; A Imagawa; S Tamura; M Inada
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

Review 7.  Immune-mediated β-cell death in type 1 diabetes: lessons from human β-cell lines.

Authors:  Yaíma L Lightfoot; Jing Chen; Clayton E Mathews
Journal:  Eur J Clin Invest       Date:  2012-08-25       Impact factor: 4.686

8.  Intercellular adhesion molecule-1 (ICAM-1) in Graves' disease: contrast between in vivo and in vitro results.

Authors:  A Ciampolillo; G Napolitano; R Mirakian; A Miyasaki; R Giorgino; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

Review 9.  Alpha E: no more rejection?

Authors:  Peter J Kilshaw; Jonathan M G Higgins
Journal:  J Exp Med       Date:  2002-10-07       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.